Bioprinted Constructs in the Regulatory Landscape: Current State and Future Perspectives
Advanced Materials · 2026-01 · 38 (4)
DOI: 10.1002/adma.202504037 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 16.10.2025. Verfasst von Francesca Perin und 6 weiteren Autor:innen. Beteiligte Einrichtung: MERLN Institute, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, 6229ER, Netherlands. Hauptthemen laut MEDLINE: Bioprinting. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: H2020 Future and Emerging Technologies.
Abstract (Originalsprache)
Bioprinting has become one of the leading topics in biomedical research in the past decade, as demonstrated by the great surge in publications and proliferation of bioprinting facilities worldwide. Bioprinting has gained widespread popularity because of its potential to replicate complex biological structures, revolutionize in vitro testing, and tissue engineering. However, the clinical translation of bioprinted products remains a challenge. The regulatory approval of tissue‐engineered products requires extensive preclinical and clinical trials with different standards worldwide. The regulatory landscape for bioprinted products is examined in the European Union, United States, China, and Australia. The current regulatory status of bioprinting is traced by exploring parallels with existing categories such as 3D printed medical devices, injectable hydrogels, and tissue engineering products. This perspective provides a comprehensive overview of the current state and regulatory landscape of bioprinted constructs, envisioning challenges, and strategies for their future integration into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MERLN Institute, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, 6229ER, Netherlands.
- BioTech, Department of Industrial Engineering, University of Trento, Trento, 38123, Italy.
- Department of Mechanical Engineering, Tsinghua University, Beijing, 100084, China.
- School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2052, Australia.
ORCID-Profile: Francesca Perin, Liliang Ouyang, Khoon S Lim, Antonella Motta, Devid Maniglio, Lorenzo Moroni, Carlos Mota
Förderung
- H2020 Future and Emerging Technologies
Zitieren
APA
Perin, F., Ouyang, L., Lim, K. S., Motta, A., Maniglio, D., Moroni, L., & Mota, C. (2026). Bioprinted Constructs in the Regulatory Landscape: Current State and Future Perspectives. Advanced Materials, 38(4). https://doi.org/10.1002/adma.202504037
Vancouver
Perin F, Ouyang L, Lim KS, Motta A, Maniglio D, Moroni L, et al. Bioprinted Constructs in the Regulatory Landscape: Current State and Future Perspectives. Advanced Materials. 2026;38(4). doi:10.1002/adma.202504037
BibTeX
@article{Perin2026,
author = {Perin, Francesca and Ouyang, Liliang and Lim, Khoon S and Motta, Antonella and Maniglio, Devid and Moroni, Lorenzo and Mota, Carlos},
title = {Bioprinted Constructs in the Regulatory Landscape: Current State and Future Perspectives},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {4},
doi = {10.1002/adma.202504037}
}
EUVIMED